Liquid Dosage
Cutting-edge upstream and downstream bioprocessing equipment
GEA specializes in the planning, construction and qualification of sterile process plant for the pharmaceutical and biotechnology industries. Experts in aseptic process management, closed product handling, compliance with GMP requirements, gentle product treatment, the efficient recovery of active ingredients and reliable scale-up, we supply modules, components and complete lines for the production and purification of biotechnologically manufactured products such as vaccines, hormones and other therapeutic agents.
In addition, GEA offers plant for the formulation of syrups, suspensions, parenterals and blood plasma fractionation. Systems for the production, storage, and distribution of clean utilities and media complete the portfolio.
With a proven track record in processes such as preformulation and API production, including fermentation, clarification, membrane filtration and separation, homogenization and micronization, crystallization, classification, concentration, lyophilization and fractionation, as well as complete integration with upstream and downstream processes, GEA’s standalone machines or package units guarantee a high yield of valuable substances and operate efficiently, reliably and economically throughout a long service life.
Process Modules
Our equipment portfolio includes a comprehensive range of standard and customized vessels, bioreactors, fermenters and flow components, as well as advanced processing modules for the dairy, food and juice industries.
Complete Application Support
Whether you produce infusion solutions, electrolytes, anesthetics, oncology drugs, inhalables, monoclonal antibodies (mAbs), vaccines or therapeutic proteins, or whether you’re a manufacturer of serums, injection solutions, insulin or drop solutions, our wide range of modular plant and equipment performs any task and takes account of any specific requirements or conditions.
Produits et technologies
Affichage de 4 sur 17
Bloc de compression pour homogénéisateur
Les têtes de compression de GEA constituent le cœur des homogénéisateurs, car elles activent le processus d'homogénéisation en pompant le produit à haute pression jusqu'à ce qu'il s'écoule dans la vanne d'homogénéisation.
Décanteur centrifuge
Le décanteur est appelé à intervenir dès que la teneur en matières solides dans la suspension à traiter atteint un niveau particulièrement élevé. Ces machines offrent l'avantage d'un rendement de clarification élevé et d'une déshydratation optimale, et assurent en outre la séparation des liquides tout en éliminant les matières soli...
GEA Cleaning Technology
The portfolio comprises different types of cleaning devices, such as orbital, rotating and static cleaners, to achieve the optimum cleaning result for different applications. Cleaning technology products can be found working successfully all over the world in numerous industries – from water treatment, chemical and brewing to food and pharmaceuti...
Homogénéisateurs de laboratoire
Les homogénéisateurs de laboratoire de GEA sont de petite taille et compacts. Ils permettent de tester les effets de l'homogénéisation sur le produit et d'évaluer les meilleurs paramètres de process.
Downloads
GEA Insights
Des onglons sains, des vaches en meilleure santé
Les exploitations laitières reposent sur une base simple mais essentielle : des onglons sains. Lorsque ces fondations s'affaiblissent, les performances, le bien-être et l'efficacité s'en ressentent rapidement, quel que soit le niveau de développement de l'exploitation.
GEA opens new technology center, strengthening its position in the growing pharmaceutical applications market
Together with Mona Neubaur, Minister of Economic Affairs of the German state of North Rhine-Westphalia, GEA CEO Stefan Klebert has opened a new technology center for pharmaceutical freeze-drying systems in Elsdorf, Germany. GEA employs approximately 260 people at the facility, which combines research and development with production and service under one roof.
